Healthcare
Cambridge Nutritional Sciences Ltd.(CNSL)
Live Price
Offline$1.75
+0.00% today
1Y Change
-50.00%
Window
Jun 26, 2025 โ Jun 15, 2026
- Market Cap
- $550.00M
- Revenue Growth
- -6.8%
- EPS Growth
- -63.5%
- Dividend Yield
- 0.0%
Coverage: 244 bars ยท Jun 26, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Cambridge Nutritional Sciences Ltd. (CNSL) is a Healthcare stock with a market cap of $550.00M and listed on LSE. The stock last traded around $1.75 and down 50.0% across the available one-year price window (Jun 26, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of -6.8%, EPS growth of -63.5%, a dividend yield of 0.0%. What stands out right now is revenue -6.8%, EPS -63.5%, free cash flow -1.1% with operating margin -14.2% and ROIC -4.0%. Valuation is more restrained than many high-expectation growth names at price/sales 0.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CNSL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-6.8% vs +7.6% peer median
Operating Margin
Below sector median
-14.2% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
2024 was reported on Nov 5, 2024 with an EPS surprise of +28.3% and a revenue surprise of +2.2%.
The operating picture looks softer than before
Revenue is at -6.8% and EPS is at -63.5%, with operating margin around -14.2%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +6.9% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2024 Nov 5, 2024 | +28.3% | +0.0% | +6.9% | +4.2% |
2024 Aug 6, 2024 | +13.9% | +0.0% | +6.9% | +4.2% |
2024 May 7, 2024 | +37.2% | +0.0% | +6.9% | +4.2% |
Benchmark Edge
CNSL vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CNSL
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CNSL Max Drawdown
-54.55%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CNSL and SPY.
Company Overview
Cambridge Nutritional Sciences Ltd.
LSE
Cambridge Nutritional Sciences Ltd. is a pioneering company in the field of nutritional diagnostics and personalized health assessments. The primary purpose of the company is to provide innovative diagnostic solutions that enable healthcare professionals and individuals to identify specific nutritional needs and food sensitivities. Through its range of high-quality testing kits, Cambridge Nutritional Sciences Ltd. empowers clients to make informed dietary and lifestyle choices that improve overall health and wellness. Notably, the company's offerings include specialized tests for food intolerance, vitamin deficiencies, and gut health, impacting industries such as healthcare, nutrition counseling, and wellness programs. These diagnostic tools aid in the customization of nutrition plans, supporting a growing trend towards personalized medicine and preventative healthcare practices. With a focus on scientific research and development, Cambridge Nutritional Sciences Ltd. plays a significant role in advancing the market for functional health diagnostics. By addressing the increasing demand for personalized health solutions, the company contributes to more proactive and tailored healthcare approaches, making it a key player in the evolving landscape of health and wellness.
- Leadership
- Mr. James Cooper B.A., M.Sc.
- Employees
- 84
- Street Address
- One Fleet Place
- Mailing
- London, EC4M 7WS
- Region
- London, United Kingdom
- Last Updated
- May 8, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 15.6
- Price/Sales
- 0.5
- Price/Book
- 0.7
Growth
- Revenue
- -6.8%
- EPS
- -63.5%
- Free Cash Flow
- -1.1%
Profitability
- Gross Margin
- 53.9%
- Operating Margin
- -14.2%
- Net Margin
- -22.6%
- ROE
- -27.7%
- ROIC
- -4.0%
Balance Sheet
- Debt/Equity
- 2.83
- Current Ratio
- 0.81
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.